Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Days.
The item "Cash-Conversion-Cycle" stands at 93.27 days as of 06/30/2025.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Cash Conversion Cycle" stands at 93.27 Days. This represents a decrease of -3.09 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.08 percent compared to the value the year prior.
The 1 year change in percent is 7.08.
The 3 year change in percent is 104.78.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Conversion Cycle | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Conversion Cycle | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Conversion Cycle | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Conversion Cycle | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Conversion Cycle | 280,205,508,085.11 |